$SNBR
Sleep Number Corp Stock $snbr

$snbr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000082718724000011 Filed on February 23, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$470.4M	$429.5M	$1.887B
YoY Change		-20.54%	-13.61%
Cost Of Revenue	$194.3M	$186.6M	$799.0M
YoY Change		-21.42%	-7.75%
Gross Profit	$276.2M	$242.9M	$1.089B
YoY Change		-19.86%	-17.46%
Gross Profit Margin	58.7%	56.55%	57.67%
Selling, General & Admin	$247.6M	$233.5M	$994.1M
YoY Change		-15.29%	-6.82%
% of Gross Profit	89.65%	96.13%	91.32%
Research & Development	$12.44M	$13.28M	$55.80M
YoY Change		-10.21%	-4.69%
% of Gross Profit	4.5%	5.47%	5.13%
Depreciation & Amortization	$17.49M	$18.84M	$74.04M
YoY Change		8.5%	22.6%
% of Gross Profit	6.33%	7.76%	6.8%
Operating Expenses	$260.0M	$246.8M	$1.066B
YoY Change		-15.03%	-5.31%
Operating Profit	$16.14M	-$3.876M	$22.94M
YoY Change		-130.66%	-88.15%
Interest Expense	-$12.30M	-$12.69M	-$42.70M
YoY Change		126.31%	583.67%
% of Operating Profit	-76.19%		-186.1%
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.757M	-$32.29M	-$19.75M
YoY Change		-558.94%	-110.55%
Income Tax	$725.0K	-$7.103M	-$4.466M
% Of Pretax Income
Net Earnings	-$7.482M	-$25.19M	-$15.29M
YoY Change		-600.46%	-109.94%
Net Earnings / Revenue	-1.59%	-5.86%	-0.81%
Basic Earnings Per Share	-$0.33		-$0.68
Diluted Earnings Per Share	-$0.33	-$1.12	-$0.68
COMMON SHARES
Basic Shares Outstanding	22.24M shares		22.43M shares
Diluted Shares Outstanding	22.51M shares		22.43M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.068M	$2.539M	$2.539M
YoY Change		88.35%	6.28%
Cash & Equivalents	$2.068M	$2.539M	$2.539M
Short-Term Investments
Other Short-Term Assets	$56.24M	$44.64M	$61.30M
YoY Change		-20.32%	33.77%
Inventory	$100.9M	$115.4M	$115.4M
Prepaid Expenses	$20.66M	$16.66M
Receivables	$21.83M	$26.86M	$26.86M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$181.0M	$206.1M	$206.1M
YoY Change		4.28%	-0.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$555.0M	$179.5M	$574.9M
YoY Change		-69.55%	1.53%
Goodwill	$64.00M	$64.00M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.9M	$82.95M	$103.2M
YoY Change		-2.42%	299.29%
Total Long-Term Assets	$727.4M	$744.8M	$744.8M
YoY Change		0.22%	4.61%
TOTAL ASSETS
Total Short-Term Assets	$181.0M	$206.1M	$206.1M
Total Long-Term Assets	$727.4M	$744.8M	$744.8M
Total Assets	$908.5M	$950.9M	$950.9M
YoY Change		1.07%	3.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$125.3M	$135.9M	$135.9M
YoY Change		-31.76%	-16.39%
Accrued Expenses	$148.7M	$149.6M	$149.6M
YoY Change		-7.44%	-11.0%
Deferred Revenue
YoY Change
Short-Term Debt	$523.5M	$539.5M	$539.5M
YoY Change		32.78%	41.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$906.2M	$936.1M	$936.1M
YoY Change		1.39%	3.23%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$448.1M	$105.3M	$456.7M
YoY Change		-76.85%	4.51%
Total Long-Term Liabilities	$448.1M	$105.3M	$456.7M
YoY Change		-76.85%	4.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$906.2M	$936.1M	$936.1M
Total Long-Term Liabilities	$448.1M	$105.3M	$456.7M
Total Liabilities	$1.354B	$1.393B	$1.393B
YoY Change		1.06%	3.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$466.3M	-$458.9M
YoY Change		4.73%
Common Stock	$20.49M	$16.94M
YoY Change		2398.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$445.9M	-$441.9M	-$441.9M
YoY Change
Total Liabilities & Shareholders Equity	$908.5M	$950.9M	$950.9M
YoY Change		1.07%	3.41%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$7.482M	-$25.19M	-$15.29M
YoY Change		-600.46%	-109.94%
Depreciation, Depletion And Amortization	$17.49M	$18.84M	$74.04M
YoY Change		8.5%	22.6%
Cash From Operating Activities	$33.75M	-$40.83M	-$9.028M
YoY Change		-179.38%	-103.01%
INVESTING ACTIVITIES
Capital Expenditures	$9.308M	$9.056M	$57.06M
YoY Change		-155.73%	-14.71%
Acquisitions
YoY Change
Other Investing Activities	-$2.942M	$4.000K	-$1.296M
YoY Change		-84.62%	-604.28%
Cash From Investing Activities	-$12.25M	-$9.052M	-$58.35M
YoY Change		-44.2%	-12.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.319M
YoY Change			-99.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.97M	51.53M	$68.13M
YoY Change		-242.58%	-128.96%
NET CHANGE
Cash From Operating Activities	33.75M	-40.83M	-$9.028M
Cash From Investing Activities	-12.25M	-9.052M	-$58.35M
Cash From Financing Activities	-21.97M	51.53M	$68.13M
Net Change In Cash	-471.0K	1.647M	$747.0K
YoY Change		-276.91%	-140.29%
FREE CASH FLOW
Cash From Operating Activities	$33.75M	-$40.83M	-$9.028M
Capital Expenditures	$9.308M	$9.056M	$57.06M
Free Cash Flow	$24.44M	-$49.88M	-$66.08M
YoY Change		-173.71%	-128.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	64188000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-438177000	usd
CY2022	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	97647000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1131000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4441000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2017000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68127000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1792000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19753000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4466000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12285000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33545000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15287000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	36610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	153746000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.40
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24038000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15287000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	428000	usd
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2539000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1792000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1437000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1267000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26859000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26005000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	115433000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	114034000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16660000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16006000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	44637000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	39921000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	206128000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	197758000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179503000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	200605000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	395411000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	397755000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	66634000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	68065000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	20253000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7958000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82951000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81795000	usd
CY2023Q4	us-gaap	Assets Assets	950880000	usd
CY2022Q4	us-gaap	Assets Assets	953936000	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	539500000	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	459600000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	135901000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	176207000	usd
CY2023Q4	snbr	Customer Prepayments Current CustomerPrepaymentsCurrent	49143000	usd
CY2022Q4	snbr	Customer Prepayments Current CustomerPrepaymentsCurrent	73181000	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	22402000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	25594000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28273000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31291000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17134000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	23622000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81760000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79533000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	61958000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60785000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	936071000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	929813000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	351394000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	356879000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	105343000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	105421000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1392808000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1392113000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	142500000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	142500000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22235000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22235000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22014000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22014000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	222000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	220000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16716000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5182000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-458866000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443579000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-441928000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-438177000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	950880000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	953936000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1887482000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2114297000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2184949000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	798952000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	912001000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	866102000	usd
CY2023	us-gaap	Gross Profit GrossProfit	1088530000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1202296000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1318847000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	847442000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	919629000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	905359000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	146621000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	153266000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	161412000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61521000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58540000	usd
CY2022	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-42695000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18985000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6245000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	48895000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22429000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22396000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.16
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22429000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22852000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24947000	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-223978000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	153746000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4441000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23214000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	382376000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-424953000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	36610000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1131000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14855000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3747000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-441928000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15287000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	36610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	153746000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74043000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67401000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	60394000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	14855000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13223000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	23214000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-2898000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-291000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-37000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12295000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8646000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	446000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	854000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	287000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6153000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1399000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11560000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24282000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-5969000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1356000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-3066000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5220000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19379000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13836000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28934000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4743000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	54405000	usd
CY2023	snbr	Increase Decrease In Prepayments From Customer IncreaseDecreaseInPrepaymentsFromCustomer	-24038000	usd
CY2022	snbr	Increase Decrease In Prepayments From Customer IncreaseDecreaseInPrepaymentsFromCustomer	-56318000	usd
CY2022	snbr	Increase Decrease In Prepayments From Customer IncreaseDecreaseInPrepaymentsFromCustomer	57482000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2943000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-19821000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-24790000	usd
CY2023	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-519000	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	179000	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	1814000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3366000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-926000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8293000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9028000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36138000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	300010000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57056000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69454000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66900000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	21000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	49000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	257000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1317000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	1202000	usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-66643000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3747000	usd
CY2023	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	73463000	usd
CY2022	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	145473000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	428000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	718000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2759000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33872000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-235221000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	747000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-597000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1854000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2389000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4243000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2539000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1792000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2389000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13716000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	19792000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36305000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	40570000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	16918000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5438000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6670000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	11707000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	13968000	usd
CY2023	us-gaap	Fiscal Period FiscalPeriod	<div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on the Saturday closest to December 31. Fiscal years and their respective fiscal year ends were as follows: fiscal 2023 ended December 30, 2023; fiscal 2022 ended December 31, 2022; and fiscal 2021 ended January 1, 2022. Fiscal 2023, 2022 and 2021 each had 52 weeks.</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires the Company to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition.</span></div>
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2023Q4	us-gaap	Goodwill Goodwill	64000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	64000000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	1200000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8997000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	10069000	usd
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	12152000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	15939000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	16694000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	16732000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	16438000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	17157000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	18134000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	5000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-609000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-681000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8503000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8997000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	10069000	usd
CY2023	snbr	Leverage Ratio LeverageRatio	3.00
CY2023	snbr	Leverage Ratio LeverageRatio	3.00
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	348000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	600000000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	272000000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	309000000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	323000000	usd
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	13000000	usd
CY2023Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	13000000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	8000000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	9000000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	5000000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	4000000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1200000	shares
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	7785000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	92000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	102000	usd
CY2023Q4	snbr	Inventory Finished Goods And Components Net InventoryFinishedGoodsAndComponentsNet	106249000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	9092000	usd
CY2022Q4	snbr	Inventory Finished Goods And Components Net InventoryFinishedGoodsAndComponentsNet	106147000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	115433000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	114034000	usd
CY2023Q4	snbr	Finished Beds Included In Finished Goods Inventory Net FinishedBedsIncludedInFinishedGoodsInventoryNet	39235000	usd
CY2022Q4	snbr	Finished Beds Included In Finished Goods Inventory Net FinishedBedsIncludedInFinishedGoodsInventoryNet	36708000	usd
CY2023Q4	snbr	Finished Components Included In Finished Goods Inventory Net FinishedComponentsIncludedInFinishedGoodsInventoryNet	46179000	usd
CY2022Q4	snbr	Finished Components Included In Finished Goods Inventory Net FinishedComponentsIncludedInFinishedGoodsInventoryNet	45722000	usd
CY2023Q4	snbr	Retail Accessories Included In Finished Goods Inventory Net RetailAccessoriesIncludedInFinishedGoodsInventoryNet	20835000	usd
CY2022Q4	snbr	Retail Accessories Included In Finished Goods Inventory Net RetailAccessoriesIncludedInFinishedGoodsInventoryNet	23717000	usd
CY2023Q4	snbr	Inventory Finished Goods And Components Net InventoryFinishedGoodsAndComponentsNet	106249000	usd
CY2022Q4	snbr	Inventory Finished Goods And Components Net InventoryFinishedGoodsAndComponentsNet	106147000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	435336000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	390343000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179503000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	200605000	usd
CY2023	us-gaap	Depreciation Depreciation	71000000	usd
CY2022	us-gaap	Depreciation Depreciation	64000000	usd
CY2022	us-gaap	Depreciation Depreciation	57000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.085
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.067
CY2023Q4	us-gaap	Goodwill Goodwill	64000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	64000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20823000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19631000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20823000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	222000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	226000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	222000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	222000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	155000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	145000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1192000	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	539500000	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	459600000	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	7147000	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	5947000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	138353000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	359453000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	113510000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	109766000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	99474000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	278000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	877000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	2205000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	106670000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	97359000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	85276000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	69744000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	57767000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	103541000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	520357000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	87203000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	433154000	usd
CY2023Q4	snbr	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	25000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	108294000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	99819000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	90198000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	69396000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	82117000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	109000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14855000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13223000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23214000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3476000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3319000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5722000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	11379000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	9904000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	17492000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	787000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	829000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	305000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	27.30
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	21.43
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	26000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	55.69
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1046000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.80
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	654000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	42.08
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1014000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	40.87
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.41
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	30.22
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	71.93
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	298000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1298000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	16003000	usd
CY2023	snbr	Stock Repurchased Acquired Through Share Repurchase Program Total StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal	0	usd
CY2022	snbr	Stock Repurchased Acquired Through Share Repurchase Program Total StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal	54868000	usd
CY2022	snbr	Stock Repurchased Acquired Through Share Repurchase Program Total StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal	364479000	usd
CY2023	snbr	Stock Repurchase Acquired Through Tax Withholding Restricted Stock StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock	3747000	usd
CY2022	snbr	Stock Repurchase Acquired Through Tax Withholding Restricted Stock StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock	9320000	usd
CY2022	snbr	Stock Repurchase Acquired Through Tax Withholding Restricted Stock StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock	17897000	usd
CY2023	snbr	Stock Repurchase During Period Value Disclosure StockRepurchaseDuringPeriodValueDisclosure	3747000	usd
CY2022	snbr	Stock Repurchase During Period Value Disclosure StockRepurchaseDuringPeriodValueDisclosure	64188000	usd
CY2022	snbr	Stock Repurchase During Period Value Disclosure StockRepurchaseDuringPeriodValueDisclosure	382376000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	600000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	348000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15287000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	36610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	153746000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22429000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22396000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24038000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	456000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	909000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22429000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22852000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24947000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.40
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.16
CY2023Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	83362000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	83685000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	105519000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	107334000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36000000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	34000000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	29000000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1887482000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2114297000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2184949000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	25594000	usd
CY2022Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	22368000	usd
CY2023	snbr	Contract With Customer Refund Liability Additions ContractWithCustomerRefundLiabilityAdditions	109153000	usd
CY2022	snbr	Contract With Customer Refund Liability Additions ContractWithCustomerRefundLiabilityAdditions	103477000	usd
CY2023	snbr	Contract With Customer Refund Liability Deductions ContractWithCustomerRefundLiabilityDeductions	112345000	usd
CY2022	snbr	Contract With Customer Refund Liability Deductions ContractWithCustomerRefundLiabilityDeductions	100251000	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	22402000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	25594000	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.50
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	10000000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	10000000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	7000000	usd
CY2023Q4	us-gaap	Restructuring And Related Cost Expected Cost Remaining1 RestructuringAndRelatedCostExpectedCostRemaining1	12000000	usd
CY2023Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	15700000	usd
CY2023Q4	us-gaap	Restructuring Costs RestructuringCosts	13486000	usd
CY2023Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2242000	usd
CY2023Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	15728000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	13486000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	4766000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	8720000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5474000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15518000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17019000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3106000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5174000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4568000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8580000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20692000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	21587000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10151000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7264000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	10954000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2895000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1143000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1004000	usd
CY2023	snbr	Deferred Income Tax Expense Benefit Net DeferredIncomeTaxExpenseBenefitNet	-13046000	usd
CY2022	snbr	Deferred Income Tax Expense Benefit Net DeferredIncomeTaxExpenseBenefitNet	-8407000	usd
CY2022	snbr	Deferred Income Tax Expense Benefit Net DeferredIncomeTaxExpenseBenefitNet	11958000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4466000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12285000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33545000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.035
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.064
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.141
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.055
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.014
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.061
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Investment EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment	-0.011
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Investment EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Investment EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.062
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.012
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.063
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.057
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.017
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.015
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.028
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.005
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.226
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.251
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7006000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6896000	usd
CY2023Q4	snbr	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	108952000	usd
CY2022Q4	snbr	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	109144000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	6894000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	7881000	usd
CY2023Q4	snbr	Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards And Deferred Tax Credits DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwardsAndDeferredTaxCredits	1738000	usd
CY2022Q4	snbr	Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards And Deferred Tax Credits DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwardsAndDeferredTaxCredits	2051000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	7484000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	7678000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	18079000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	13860000	usd
CY2023Q4	snbr	Deferred Tax Assets Tax Deferred Expense Other Long Term DeferredTaxAssetsTaxDeferredExpenseOtherLongTerm	8931000	usd
CY2022Q4	snbr	Deferred Tax Assets Tax Deferred Expense Other Long Term DeferredTaxAssetsTaxDeferredExpenseOtherLongTerm	6110000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	159084000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	153620000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	615000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	159036000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	153005000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	33772000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	38442000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	99351000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	99311000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	3065000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	4394000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2595000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	138783000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	145047000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20253000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7958000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3645000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3869000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3912000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	753000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	910000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	831000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	40000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	252000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	328000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	33000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	601000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1058000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	845000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	166000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3671000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3645000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3869000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3400000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3200000	usd
CY2022Q4	snbr	Number Of Shareholder Litigation Demands NumberOfShareholderLitigationDemands	2	litigationdemand
CY2023Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	35000000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
0000827187-24-000011-index-headers.html	Edgar Link	pending
0000827187-24-000011-index.html	Edgar Link	pending
0000827187-24-000011.txt	Edgar Link	pending
0000827187-24-000011-xbrl.zip	Edgar Link	pending
a2023-q4ex1015.htm	Edgar Link	pending
a2023-q4ex1016.htm	Edgar Link	pending
a2023-q4ex1017.htm	Edgar Link	pending
a2023-q4ex211.htm	Edgar Link	pending
a2023-q4ex231.htm	Edgar Link	pending
a2023-q4ex311.htm	Edgar Link	pending
a2023-q4ex312.htm	Edgar Link	pending
a2023-q4ex321.htm	Edgar Link	pending
a2023-q4ex322.htm	Edgar Link	pending
a2023-q4ex971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
snbr-20231230.htm	Edgar Link	pending
snbr-20231230.xsd	Edgar Link	pending
snbr-20231230_g1.jpg	Edgar Link	pending
snbr-20231230_def.xml	Edgar Link	unprocessable
snbr-20231230_lab.xml	Edgar Link	unprocessable
snbr-20231230_pre.xml	Edgar Link	unprocessable
snbr-20231230_htm.xml	Edgar Link	completed
snbr-20231230_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SNBR
Sleep Number Corp Stock $snbr

2024 Q1 Form 10-K Financial Statement

#000082718724000011 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNBR Sleep Number Corp Stock $snbr

2024 Q1 Form 10-K Financial Statement

#000082718724000011 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNBR
Sleep Number Corp Stock $snbr